Global Device Market Barriers, Strategies Detailed For U.S. Trade Report
This article was originally published in The Gray Sheet
Executive Summary
Increased medical equipment import tariffs of up to 51% within India's 2002-2003 budget will add millions of dollars in costs for U.S. device companies, AdvaMed asserts in a Dec. 13 statement to the Office of the U.S. Trade Representative
You may also be interested in...
International News In Brief
FDA Office of International Programs: OIP action plan will coordinate agency's international activities with "overall U.S. government objectives," Commissioner Mark McClellan says in Feb. 27 memo to agency employees. Charged with leading FDA efforts on embassy relations and trade agreements, the office will "leverage resources with counterpart agencies on a risk-benefit basis." Standard operating procedures will be developed in the coming weeks...
International News In Brief
FDA Office of International Programs: OIP action plan will coordinate agency's international activities with "overall U.S. government objectives," Commissioner Mark McClellan says in Feb. 27 memo to agency employees. Charged with leading FDA efforts on embassy relations and trade agreements, the office will "leverage resources with counterpart agencies on a risk-benefit basis." Standard operating procedures will be developed in the coming weeks...
Asia Update: U.S. Queries Looming Japanese Reforms, Korean Bill In Works
Improved review times are a necessary pre-condition of Japan's nascent user free program if the Ministry of Health, Labor and Welfare expects U.S. firms to comply with the initiative, according to AdvaMed